Selected research
Market Structure
Global Gene Synthesis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gene Synthesis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Gene Synthesis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Synthesis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Synthesis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gene Synthesis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gene Synthesis Software include Eurofins Genomics, ATUM, Biotage, Bioneer Corporation, Eurogentec, GenScript, GENEWIZ, Integrated DNA Technologies and OriGene Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Gene Synthesis Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Synthesis Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Synthesis Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Synthesis Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Gene Synthesis Software Segment by Company
Eurofins Genomics
ATUM
Biotage
Bioneer Corporation
Eurogentec
GenScript
GENEWIZ
Integrated DNA Technologies
OriGene Technologies
Thermo Fisher Scientific
Bio Basic
Twist Bioscience
BioCat GmbH
ProteoGenix
Charles River
Biosearch Technologies
Beijing SBS Genetech
Eton Bioscience
Gene Synthesis Software Segment by Type
Solid Phase Synthesis
Chip-based DNA Synthesis
PCR-based Enzyme Synthesis
Gene Synthesis Software Segment by Application
Academic and Research Institutes
Biotech and Pharmaceutical
Diagnostic Laboratories
Others
Gene Synthesis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Synthesis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Synthesis Software industry.
Chapter 3: Detailed analysis of Gene Synthesis Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Synthesis Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Phase Synthesis
- Chip-based DNA Synthesis
- PCR-based Enzyme Synthesis
Applications
- Academic and Research Institutes
- Biotech and Pharmaceutical
- Diagnostic Laboratories
- Others
Companies covered
- Eurofins Genomics
- ATUM
- Biotage
- Bioneer Corporation
- Eurogentec
- GenScript
- GENEWIZ
- Integrated DNA Technologies
- OriGene Technologies
- Thermo Fisher Scientific
- Bio Basic
- Twist Bioscience
- BioCat GmbH
- ProteoGenix
- Charles River
- Biosearch Technologies
- Beijing SBS Genetech
- Eton Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Synthesis Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Solid Phase Synthesis
- 1.2.3 Chip-based DNA Synthesis
- 1.2.4 PCR-based Enzyme Synthesis
- 1.3 Market Analysis by Application
- 1.3.1 Global Gene Synthesis Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Academic and Research Institutes
- 1.3.3 Biotech and Pharmaceutical
- 1.3.4 Diagnostic Laboratories
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Gene Synthesis Software Growth Trends by Region
- 1.5.1 Global Gene Synthesis Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Gene Synthesis Software Market Size by Region (2021-2026)
- 1.5.3 Gene Synthesis Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Gene Synthesis Software Market Dynamics
- 2.1 Gene Synthesis Software Industry Trends
- 2.2 Gene Synthesis Software Industry Drivers
- 2.3 Gene Synthesis Software Industry Opportunities and Challenges
- 2.4 Gene Synthesis Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Gene Synthesis Software Revenue by Company (2021-2026)
- 3.2 Global Gene Synthesis Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Gene Synthesis Software Key Company Head office and Area Served
- 3.4 Global Gene Synthesis Software Company, Product Type & Application
- 3.5 Global Gene Synthesis Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Gene Synthesis Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Gene Synthesis Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Gene Synthesis Software Tier 1, Tier 2, and Tier 3
4 Gene Synthesis Software Market by Type
- 4.1 Global Gene Synthesis Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Gene Synthesis Software Market Size by Type (2021-2032)
- 4.3 Global Gene Synthesis Software Market Size Share by Type (2021-2032)
5 Gene Synthesis Software Market by Application
- 5.1 Global Gene Synthesis Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Gene Synthesis Software Market Size by Application (2021-2032)
- 5.3 Global Gene Synthesis Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Eurofins Genomics
- 6.1.1 Eurofins Genomics Company Information
- 6.1.2 Eurofins Genomics Business Overview
- 6.1.3 Eurofins Genomics Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Eurofins Genomics Gene Synthesis Software Product Portfolio
- 6.1.5 Eurofins Genomics Recent Developments
- 6.2 ATUM
- 6.2.1 ATUM Company Information
- 6.2.2 ATUM Business Overview
- 6.2.3 ATUM Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 ATUM Gene Synthesis Software Product Portfolio
- 6.2.5 ATUM Recent Developments
- 6.3 Biotage
- 6.3.1 Biotage Company Information
- 6.3.2 Biotage Business Overview
- 6.3.3 Biotage Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Biotage Gene Synthesis Software Product Portfolio
- 6.3.5 Biotage Recent Developments
- 6.4 Bioneer Corporation
- 6.4.1 Bioneer Corporation Company Information
- 6.4.2 Bioneer Corporation Business Overview
- 6.4.3 Bioneer Corporation Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bioneer Corporation Gene Synthesis Software Product Portfolio
- 6.4.5 Bioneer Corporation Recent Developments
- 6.5 Eurogentec
- 6.5.1 Eurogentec Company Information
- 6.5.2 Eurogentec Business Overview
- 6.5.3 Eurogentec Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Eurogentec Gene Synthesis Software Product Portfolio
- 6.5.5 Eurogentec Recent Developments
- 6.6 GenScript
- 6.6.1 GenScript Company Information
- 6.6.2 GenScript Business Overview
- 6.6.3 GenScript Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GenScript Gene Synthesis Software Product Portfolio
- 6.6.5 GenScript Recent Developments
- 6.7 GENEWIZ
- 6.7.1 GENEWIZ Company Information
- 6.7.2 GENEWIZ Business Overview
- 6.7.3 GENEWIZ Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 GENEWIZ Gene Synthesis Software Product Portfolio
- 6.7.5 GENEWIZ Recent Developments
- 6.8 Integrated DNA Technologies
- 6.8.1 Integrated DNA Technologies Company Information
- 6.8.2 Integrated DNA Technologies Business Overview
- 6.8.3 Integrated DNA Technologies Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Integrated DNA Technologies Gene Synthesis Software Product Portfolio
- 6.8.5 Integrated DNA Technologies Recent Developments
- 6.9 OriGene Technologies
- 6.9.1 OriGene Technologies Company Information
- 6.9.2 OriGene Technologies Business Overview
- 6.9.3 OriGene Technologies Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 OriGene Technologies Gene Synthesis Software Product Portfolio
- 6.9.5 OriGene Technologies Recent Developments
- 6.10 Thermo Fisher Scientific
- 6.10.1 Thermo Fisher Scientific Company Information
- 6.10.2 Thermo Fisher Scientific Business Overview
- 6.10.3 Thermo Fisher Scientific Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Thermo Fisher Scientific Gene Synthesis Software Product Portfolio
- 6.10.5 Thermo Fisher Scientific Recent Developments
- 6.11 Bio Basic
- 6.11.1 Bio Basic Company Information
- 6.11.2 Bio Basic Business Overview
- 6.11.3 Bio Basic Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Bio Basic Gene Synthesis Software Product Portfolio
- 6.11.5 Bio Basic Recent Developments
- 6.12 Twist Bioscience
- 6.12.1 Twist Bioscience Company Information
- 6.12.2 Twist Bioscience Business Overview
- 6.12.3 Twist Bioscience Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Twist Bioscience Gene Synthesis Software Product Portfolio
- 6.12.5 Twist Bioscience Recent Developments
- 6.13 BioCat GmbH
- 6.13.1 BioCat GmbH Company Information
- 6.13.2 BioCat GmbH Business Overview
- 6.13.3 BioCat GmbH Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 BioCat GmbH Gene Synthesis Software Product Portfolio
- 6.13.5 BioCat GmbH Recent Developments
- 6.14 ProteoGenix
- 6.14.1 ProteoGenix Company Information
- 6.14.2 ProteoGenix Business Overview
- 6.14.3 ProteoGenix Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 ProteoGenix Gene Synthesis Software Product Portfolio
- 6.14.5 ProteoGenix Recent Developments
- 6.15 Charles River
- 6.15.1 Charles River Company Information
- 6.15.2 Charles River Business Overview
- 6.15.3 Charles River Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Charles River Gene Synthesis Software Product Portfolio
- 6.15.5 Charles River Recent Developments
- 6.16 Biosearch Technologies
- 6.16.1 Biosearch Technologies Company Information
- 6.16.2 Biosearch Technologies Business Overview
- 6.16.3 Biosearch Technologies Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Biosearch Technologies Gene Synthesis Software Product Portfolio
- 6.16.5 Biosearch Technologies Recent Developments
- 6.17 Beijing SBS Genetech
- 6.17.1 Beijing SBS Genetech Company Information
- 6.17.2 Beijing SBS Genetech Business Overview
- 6.17.3 Beijing SBS Genetech Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Beijing SBS Genetech Gene Synthesis Software Product Portfolio
- 6.17.5 Beijing SBS Genetech Recent Developments
- 6.18 Eton Bioscience
- 6.18.1 Eton Bioscience Company Information
- 6.18.2 Eton Bioscience Business Overview
- 6.18.3 Eton Bioscience Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Eton Bioscience Gene Synthesis Software Product Portfolio
- 6.18.5 Eton Bioscience Recent Developments
7 North America
- 7.1 North America Gene Synthesis Software Market Size (2021-2032)
- 7.2 North America Gene Synthesis Software Market Size by Type
- 7.2.1 North America Gene Synthesis Software Market Size by Type (2021-2026)
- 7.2.2 North America Gene Synthesis Software Market Size by Type (2027-2032)
- 7.2.3 North America Gene Synthesis Software Market Share by Type (2021-2032)
- 7.3 North America Gene Synthesis Software Market Size by Application
- 7.3.1 North America Gene Synthesis Software Market Size by Application (2021-2026)
- 7.3.2 North America Gene Synthesis Software Market Size by Application (2027-2032)
- 7.3.3 North America Gene Synthesis Software Market Share by Application (2021-2032)
- 7.4 North America Gene Synthesis Software Market Size by Country
- 7.4.1 North America Gene Synthesis Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Gene Synthesis Software Market Size by Country (2021-2026)
- 7.4.3 North America Gene Synthesis Software Market Size by Country (2027-2032)
- 7.4.4 North America Gene Synthesis Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Gene Synthesis Software Market Size (2021-2032)
- 8.2 Europe Gene Synthesis Software Market Size by Type
- 8.2.1 Europe Gene Synthesis Software Market Size by Type (2021-2026)
- 8.2.2 Europe Gene Synthesis Software Market Size by Type (2027-2032)
- 8.2.3 Europe Gene Synthesis Software Market Share by Type (2021-2032)
- 8.3 Europe Gene Synthesis Software Market Size by Application
- 8.3.1 Europe Gene Synthesis Software Market Size by Application (2021-2026)
- 8.3.2 Europe Gene Synthesis Software Market Size by Application (2027-2032)
- 8.3.3 Europe Gene Synthesis Software Market Share by Application (2021-2032)
- 8.4 Europe Gene Synthesis Software Market Size by Country
- 8.4.1 Europe Gene Synthesis Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Gene Synthesis Software Market Size by Country (2021-2026)
- 8.4.3 Europe Gene Synthesis Software Market Size by Country (2027-2032)
- 8.4.4 Europe Gene Synthesis Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Gene Synthesis Software Market Size (2021-2032)
- 9.2 China Gene Synthesis Software Market Size by Type
- 9.2.1 China Gene Synthesis Software Market Size by Type (2021-2026)
- 9.2.2 China Gene Synthesis Software Market Size by Type (2027-2032)
- 9.2.3 China Gene Synthesis Software Market Share by Type (2021-2032)
- 9.3 China Gene Synthesis Software Market Size by Application
- 9.3.1 China Gene Synthesis Software Market Size by Application (2021-2026)
- 9.3.2 China Gene Synthesis Software Market Size by Application (2027-2032)
- 9.3.3 China Gene Synthesis Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Gene Synthesis Software Market Size (2021-2032)
- 10.2 Asia Gene Synthesis Software Market Size by Type
- 10.2.1 Asia Gene Synthesis Software Market Size by Type (2021-2026)
- 10.2.2 Asia Gene Synthesis Software Market Size by Type (2027-2032)
- 10.2.3 Asia Gene Synthesis Software Market Share by Type (2021-2032)
- 10.3 Asia Gene Synthesis Software Market Size by Application
- 10.3.1 Asia Gene Synthesis Software Market Size by Application (2021-2026)
- 10.3.2 Asia Gene Synthesis Software Market Size by Application (2027-2032)
- 10.3.3 Asia Gene Synthesis Software Market Share by Application (2021-2032)
- 10.4 Asia Gene Synthesis Software Market Size by Country
- 10.4.1 Asia Gene Synthesis Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Gene Synthesis Software Market Size by Country (2021-2026)
- 10.4.3 Asia Gene Synthesis Software Market Size by Country (2027-2032)
- 10.4.4 Asia Gene Synthesis Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Gene Synthesis Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Gene Synthesis Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Gene Synthesis Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Gene Synthesis Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Gene Synthesis Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Gene Synthesis Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Gene Synthesis Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Gene Synthesis Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Gene Synthesis Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Gene Synthesis Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Gene Synthesis Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Gene Synthesis Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Gene Synthesis Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Gene Synthesis Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst